our laboratory as described previously (14) . YAC is a Moloney virus-induced lymphoma of A/ J mice (2) and the ascites form is passaged in vivo in A/J mice in this laboratory.
Positive Selection of lg + Spleen Cells. The Ig* fraction of spleen cells was eluted from Petri dishes coated with Ra-mouse Fab, according to the method of Wysocki and Sato (17) . After two sequential elutions, the remaining population was 96-100% Ig + as judged by immunofluorescence.
Positive Selection of Ly5 + Cells or Thy l + Cells. Spleen cells from B6, B6-Ly5.2, BALB/c, or A/ J mice are passed through a nylon-wool column and treated with anti-Thyl.2 (final dilution 1: 20) and a selected rabbit serum as a source of complement. These cells are washed three times and incubated for 30 rain at 4oC with anti-Ly5.1 or normal mouse serum (NMS) (final dilution of 1:20) in the absence of complement. 5 ml of these cells (107/ml) are added to Petri dishes (100 × 20-ram Falcon 3003, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnord, Calif.) coated with a monolayer of sheep erythroeytes (SRBC) conjugated to protein A. Coupling of SRBC to protein A was performed according to the method of Parrish and Hayward (18); protein A-SRBC monolayers were prepared according to the method of Stulting and Burke (19) .
After a 15-min incubation of lymphocytes at 4°C, the plates are gently swirled and incubated an additional 15 min at 4°C. Unbound (nonadherent) cells are removed by gently aspirating the supernate with a Pasteur pipette. Bound cells are released from the monolayers after the addition of 2 ml of distilled water, for 15 s, followed by the addition of 2 ml of 2 N phosphatbuffered saline. This procedure lyses SRBC and permits recovery of the bound lymphocyte population. The recovered cell populations (unbound plus bound) represent -~ 80-95% of the starting (input) cell population.
Analysis of the Specificity of Positive Selection Using Ly5.1 or Thyl.2 Antiserum. Spleen cells from B6 (Ly5.1 +) mice were passed through nylon wool columns, treated with anti-Thyl + C, washed, and incubated with anti-Ly5.1 as described above. The nonadherent and adherent fractions of cells obtained after incubation on protein A-coated Petri dishes were incubated at 37°C for 3 h in RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 15% FCS. This 3-h incubation procedure is required to eliminate any mouse immunoglobulin bound to lymphocytes during the positive selection procedure. After one additional wash, the cells were then incubated with either anti-Ly5.1 or NMS + C. Background lysis (after incubation with NMS + C) was 14-18%. Analysis of the input population (nylon-passed, anti-Thyl + C-treated cells) indicated that this population contained -15% Ly5.1 + cells. Analysis of the separated populations showed that the nonadherent cell population contained <5% Ly5.1 + cells, whereas the adherent fraction contained >80% (82-87%) Ly5.1 + cells. This separation was specific because (a) separation of cells coated with anti-Ly5.1 sera that had been absorbed with B6 spleen cells (equal volumes of packed cells and antisera at a 1:5 dilution for ½ h at 4°C) did not result in the enrichment of Ly5.1 + cells in the bound population; and (b) absorption of anti-Ly5.1 sera with B6-Ly5.2 cells had no effect upon the efficiency of positive selection. Similar analysis of the specificity of selection using Thy 1.2 antisera indicated that the bound population (representing 30-34% of spleen cells) was 95-98% Thyl.2 +.
Assay for In Vitro NK Activity. NK activity was determined according to a modification of a previously described protocol (14) . 3 × 104 nlcr-labeled target cells were incubated in RPMI-1640 plus 10% fetal calf serum alone or together with different spleen cell populations at 37°C in a humidified atmosphere of 95% air, 5% COz. The amount of gamma radioactivity released from triplicate cultures after 5 h was determined. Cytotoxicity is expressed as percent specific lysis according to the following formula: (Fig. 1) . Spleen cell populations, depleted of Ly5 + cells, exerted virtually no detectable NK activity. By contrast, Ig-Thyl-populations, containing m80% Ly5 + cells after positive selection, exerted substantial NK lysis. This activity represented -~ a four-to six-fold enrichment compared to unselected spleen cells. Enhanced NK activity was a result of the enrichment of Ly5 + cells because NK activity was abolished after treatment of these cells with anti-Ly5.1 (but not anti-Ly5.2 or NMS) + C.
Results

Enrichment of In Vitro NK Activity after Positive Selection
In Vivo Activity of Ly5 + NK Cells (Table I) By contrast, spleen cells expressing the Ig-Thyl-Ly5+-surface phenotype (which account for <5% of the total spleen cell population) conferred virtually complete protection against the growth of either Rl.z31 or YAC tumor cells. This protective effect was a result of Ly5 + NK cells because no protective effects were exerted by equal numbers of viable Ig-Thy 1-cells that remained after treatment with anti-Ly5.1 +C.
Summary
Relatively large numbers of nonimmune spleen cells do not protect against the local growth of two lymphomas. However, this heterogeneous population of splenic lymphocytes contains a subset of cells that efficiently protects against in vivo tumor growth. This cell population (cell-surface phenotype Thyl.2-Ig-Ly5.1 +) represents <5% of the spleen cell population and is responsible for in vitro NK-mediated lysis.
Although these studies clearly and directly demonstrate that Ly5 + NK cells selected from a heterogeneous lymphoid population from nonimmune mice can protect syngeneic mice against local in vivo growth of two different types of tumor cells (in contrast to other lymphocyte sets within the spleen), they do not directly bear upon the role of NK cells in immunosurveillance. They do indicate that highly enriched Ig-Thyl-Ly5 ÷ cells, which account for virtually all in vitro NK activity, can retard tumor growth in vivo.
It is difficult to ascribe all anti-tumor surveillance activity to NK cells, because they probably do not recirculate freely throughout the various organ systems of the body. Perhaps NK ceils may play a role in prevention of neoplastic growth within discrete anatomic compartments where there is rapid differentiation of stem cells to mature progeny (e.g., bone marrow, spleen, and portions of the gastrointestinal tract) and may normally act to regulate the growth and differentiation of non-neoplastic stem cells. Long-term observation of chimeric mice repopulated with bone marrow from congenic or mutant donors expressing very low or very high NK activity may help to answer these questions.
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